These enzymes are linked to diabetes-induced neurodegeneration by driving processes such as cholinergic deficiency (AChE), amyloid plaque formation (BACE-1), inflammation and oxidative stress (DPP-4), and tau pathology (GSK-3β). This evidence concerns the gene MAPT and diabetes mellitus.